of an Epstein-Barr virus (EBV) vaccine candidate yesterday. The EBV vaccine is being developed in collaboration with Merck, which is known as MSD outside the United States and Canada. Per ...

Merck & Co has entered into a worldwide licensing deal with Opko Health’s ModeX Therapeutics unit for a vaccine candidate against Epstein-Barr virus (EBV) that could be worth up to $922.5 ...

Dr. Senders and the research team at Senders Pediatrics are working with Moderna on a new MRNA vaccine that seeks to wipe out the Epstein-Barr Virus, which causes mono. “The earlier study shows ...

This EBV vaccine technology was the subject of preclinical data published in May 2022 in Science Translational Medicine. Epstein-Barr virus (EBV), a member of the herpes virus family, is one of ...

Chinese Academy of Preventive Medicine (CAPM) and former president of CAPM, Shu-Yan Gu, now deputy director of the National Center for AIDS Prevention and Control, and others, is leading to ...

Multisystem inflammatory syndrome in children (MIS-C) linked to COVID-19 is associated with reactivation of Epstein-Barr virus (EBV), leading to an altered immune response, according to a study ...